From automated tablet inspection to laser printing, ENCLONY expands its market presence across North America, Europe, and Japan.
SEOUL, SOUTH KOREA, August 19, 2026 /EINPresswire.com/ — ENCLONY, a specialist in automated vision inspection equipment for the pharmaceutical industry, is accelerating its global expansion powered by its tablet and capsule inspection technology and integrated laser printing solutions.
Founded in 2013, ENCLONY develops and manufactures machine vision-based equipment that automatically inspects the appearance of tablets and capsules during the pharmaceutical manufacturing process. Its flagship PLANET EV series captures and analyzes high-speed moving tablets and capsules from multiple angles, automatically detecting foreign matter, breakage, discoloration, printing flaws, and surface defects.
Beyond conventional visual inspection, ENCLONY is expanding its product portfolio with integrated automation technology that performs laser printing and vision inspection in a single process. By laser-marking product identification information directly onto tablet surfaces and simultaneously inspecting both the print quality and overall appearance, the company supports pharmaceutical manufacturers in achieving process automation and efficient quality control.
Based on this technological strength, ENCLONY continues to expand its international client base, including major global pharmaceutical companies. The company has established a strong global track record by supplying equipment to industry leaders such as Pfizer, Johnson & Johnson, AbbVie, Viatris, and Japanese pharmaceutical firm Eisai.
In Japan, ENCLONY is strengthening its sales and technical support through its local subsidiary, Nippon ENCLONY, utilizing its Osaka showroom. In Europe, the company is broadening its reach with global clients through its European subsidiary, ENCLONY GmbH.
Technological innovation remains a key focus. ENCLONY’s high-speed inspection platform is engineered to inspect up to 425,000 tablets per hour, providing high throughput suitable for mass-production environments. Furthermore, the company continues to enhance inspection flexibility across diverse product types, operational user-friendliness, and seamless integration with existing production lines.
To further its global reach, ENCLONY actively participates in major international pharmaceutical and packaging exhibitions. At interpack 2026 in Düsseldorf, Germany, the company presented its tablet/capsule visual inspection equipment and integrated laser printing-inspection solutions to global industry professionals.
“The importance of automated inspection technology that simultaneously ensures productivity and quality control is continually rising in the global pharmaceutical industry,” said an ENCLONY representative. “Leveraging our accumulated machine vision technology and field experience, we will continue to advance inspection and automation solutions required on the manufacturing floor.”
The representative added, “We plan to reinforce local customer support in key markets, including Europe and Japan, while steadily expanding ENCLONY’s presence across the global market.”
For more information, please visit http://www.enclony.com
Young-Mi Cho
ENCLONY Co., Ltd.
ymcho@enclony.com
Legal Disclaimer:
EIN Presswire provides this news content “as is” without warranty of any kind. We do not accept any responsibility or liability
for the accuracy, content, images, videos, licenses, completeness, legality, or reliability of the information contained in this
article. If you have any complaints or copyright issues related to this article, kindly contact the author above.
Media gallery
